The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study published in the Jan. 15, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Source: Study: MS drug costs nearly triple over 7 years, even with introduction of generic